Steve MacMillan, David LaVance

Hologic President and CEO Steve MacMillan has been appointed chairman of the company's board, following the resignation of David LaVance, who has told the board he will not stand for reelection at the 2016 annual shareholders' meeting. LaVance has been on Hologic's board since 2002.

Additionally, Elaine Ullian, a current director at Hologic, has been appointed the lead independent director. Ullian is the former president and CEO of the Boston Medical Center. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.